Share price of viatris
Webb11 apr. 2024 · The trading price of Viatris Inc. (NASDAQ:VTRS) closed lower on Monday, April 10, closing at $9.85, ... VTRS’s share price would be -31.47% below current price. To … Webb12 apr. 2024 · Viatris Inc. (NASDAQ: VTRS) ... InflaRx Announces Pricing of $40 Million Public Offering of Ordinary Shares. ... Viatris to Report First Quarter 2024 Financial Results on May 8, 2024. share: Share on Facebook Tweet on Twitter Post to Reddit. April 12, 2024 - 9:00 am. PITTSBURGH, ...
Share price of viatris
Did you know?
Webb10 apr. 2024 · Viatris NasdaqGS:VTRS Stock Report Last Price US$9.85 Market Cap US$11.8b 7D 2.5% 1Y -7.9% Updated 10 Apr, 2024 Data Company Financials + 10 Analysts VTRS Stock Overview Viatris Inc. operates as a healthcare company worldwide. About the company Rewards Trading at 75% below our estimate of its fair value Became profitable … Webb31 mars 2024 · Price trends tend to persist, so it's worth looking at them when it comes to a share like Viatris. Over the past six months, its share price has outperformed the S&P500 Index by +1.07% . As of the last closing price of $9.62 , shares in Viatris were trading -8.1% below their 200 day moving average.
WebbInnovative online education platform helping global healthcare professionals address non-communicable diseases PITTSBURGH and WASHINGTON, April 6, 2024 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS),... Mar 31, 2024 WebbI am incredibly proud to share that Viatris UK has been recognised as a Top Employer 2024! For those driven to live their lives with purpose…
WebbBased on 3 Wall Street analysts offering 12 month price targets for Viatris in the last 3 months. The average price target is $15.00 with a high forecast of $16.00 and a low forecast of $14.00. The average price target represents a 52.44% change from the last price of $9.84. Highest Price Target $16.00. Average Price Target $15.00. WebbThe Creation of Viatris. In November 2024, Viatris was formed through the combination of Mylan and Upjohn, with a mission of empowering people worldwide to live healthier at every stage of life. Viatris’ name is rooted in Latin and embodies a vision of providing a path (“VIA”) to three (“TRIS”) critical goals: expanding access to ...
Webb23 mars 2024 · 7,621,706. $11.40. $11.425. $11.25. Back to VTRS Overview. Get up to 10 years of daily historical stock prices & volumes. The "Close/Last" is the “adjust …
WebbFör 1 dag sedan · Find the latest Price Book Value for Viatris (VTRS) Skip to main ... At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries ... lithium dystoniaWebb11 apr. 2024 · The share price of Viatris Inc. (VTRS) now What analysts predict: $15.63 52-week High/Low: $12.26 / $8.24 50/200 Day Moving Average: $10.94 / $10.47 This figure … impulse response of high pass filterWebbView recent trades and share price information for Viatris Inc USD0.01. USD0.01. We don’t support this browser anymore. This means our website may not look and work as you would expect. lithium dysphagiaWebbViatris Inc. historical stock charts and prices, analyst ratings, financials, and today’s real-time VTRS stock price. lithium earthwiseWebbför 2 dagar sedan · Apr 12, 202413:33 PDT. UCB +0.14% TEVA +1.74% VTRS −0.45% 6 6560 −0.22%. Belgian biopharmaceutical company UCB UCB on Wednesday lost its U.S. court appeal seeking to revive a patent covering its Parkinson's disease drug Neupro, clearing an obstacle for Teva's TEVA Actavis Laboratories UT Inc and Viatris' VTRS … lithium earnings reportWebbShare Price. as of March 31 4:00:00 PM EST. Viatris Company Stats. Industry Drugs & Biotechnology. Founded 1961. Headquarters Canonsburg, Pennsylvania. Country United … lithium early side effectsWebbför 2 dagar sedan · The stock is now trading near IIFL's price target of Rs 230. Incidently, all of these upgrades have come soon after Biocon Executive Chairperson Kiran Mazumdar Shaw told CNBC-TV18 in an interaction on March 17 that the company's stock is not well analysed and understood. "I for one, believe that our stock is not well analysed and … lithium early signs toxicity